[ORGANIZATION]
Associação Brasileira para o Estudo da Obesidade e Síndrome Metabólica
Featured in 2 tracked stories · first seen
Situations
Body image and GLP-1 medication trends in Brazil
4 clusters · 77 sources · last updated
Latest: Medical experts warn of risks from unsupervised GLP-1 weight-loss medication use
Health experts and regulatory bodies in Brazil are intensifying warnings regarding the use of GLP-1 receptor agonists, such as semaglutide and tirzepatide, for weight loss. While effective for obesity, a systematic revie